Preparation, characterization and microencapsulation of walnut (Juglans regia L.) peptides‐zinc chelate

Abstract In this research, a novel kind of walnut ( Juglans regia L.) peptides‐zinc (Zn‐WPs) chelate was obtained using the mass ratio of the walnut peptides (WPs) to ZnSO 4 .7H 2 O of 3.5:1 at pH 8.5 and 50°C for 84 min, with the chelation rate of 84.5%. In comparison to walnut peptides (WPs), the contents of aspartic acid and glutamic acid in Zn‐WPs chelate are approximately 27%, indicating that hydrophilic amino acids predominantly bind with walnut peptides. Following chelation with zinc ions, the ultraviolet‐visible (UV) characteristic absorption peak shifted from 213 nm to 210 nm, while the average particle size of the chelate increased to 8.0 ± 0.14 µm, presenting a loose spherical structure under scanning electron microscopy. These findings suggest the formation of new substances. Fourier‐transform infrared spectroscopy (FTIR) revealed carboxyl, amino, and peptide bonds as the chelation sites of WPs and zinc. The IC 50 of walnut peptides‐zinc (Zn‐WPs) chelate is 2.91 mg/mL, indicative of a favorable DPPH radical scavenging rate. Furthermore, Zn‐WPs chelate microcapsules were produced via the spray drying method, achieving an encapsulation rate of 75.67 ± 0.83% under optimal conditions. These microcapsules demonstrate robust stability across diverse environmental conditions. This study underscores the potential of Zn‐WPs and its chelate microcapsules to enhance stability and bioactivity under varying circumstances. Practical Application In this study, a new walnut peptide‐zinc (Zn‐WPs) chelate was prepared. The presence of zinc ions changes the structure and properties of walnut peptides and improves its stability. The production of Zn‐WPs chelate microcapsules enables Zn‐WPs to have strong in vitro stability under different pH and simulated gastrointestinal digestion conditions. These results provide novel insights for developing the walnut peptides as bioactive ingredients in functional foods.